A wake-up call for global access to salvage HIV drug regimens-Reference-Cited by-同舟云学术

A wake-up call for global access to salvage HIV drug regimens

Published:2007-12 Issue:9603 Volume:370 Page:1885-1887
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Mills Edward J,Nachega Jean B

Publisher

Elsevier BV

Subject

General Medicine

Reference13 articles.

1. Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study;Phillips;Lancet,2007

2. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries;Braitstein;Lancet,2006

3. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment;Ferradini;Lancet,2006

4. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort;Boulle;Antivir Ther,2007

5. Conservarion of first-line antiretroviral treatment regimen where therapeutic options are limited;Orrell;Antivir Ther,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011;Clinical Infectious Diseases;2012-04-27

2. Determinants of HIV drug resistance and public health implications in low- and middle-income countries;Antiviral Therapy;2012

3. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy;AIDS;2010-06-01

4. Association of Antiretroviral Therapy Adherence and Health Care Costs;Annals of Internal Medicine;2010-01-05

5. Expanding Antiretroviral Options in Resource-Limited Settings-A Cost-Effectiveness Analysis;JAIDS Journal of Acquired Immune Deficiency Syndromes;2009-09